Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sep 9, 2011


Bruker this week introduced its new amaZon speed and amaZon speed ETD ion trap mass spectrometers as well as its PRIME – Proteomics via Integrated MALDI and ESI – integrated solution for proteomics.

The amaZon speed instruments offer mass resolution of better than 0.5 μ in its 52,000 μ/sec XtremeScan mode and mass resolution below 0.1 μ in its 5,200 μ/sec Maximum Resolution Mode across an ITMS mass range of up to m/z 3,000, the company said. The machines offer up to five orders of dynamic range and can identify as many as 1,300 proteins in a single LC-MS/MS run of 1 g of E. coli lysate.

The PRIME system provides workflows for bottom-up and top-down proteomics work, including post-translational modification studies, quantitation, and imaging, integrating a range of technologies including MALDI-TDS, ion trap ETD, and high-resolution UHR-ESI-QTOF, the company said.

AB Sciex this week launched five new column chips for its Eksigent cHiPLC-nanoflex system.

The new chips offer high flow micro cHiPLC columns for peptide separation at increased throughput along with new phases for the analysis of intact proteins, phosphopeptides, and glycans, the company said.

GE Healthcare this week introduced its new horizontal Amersham ECL Gel System for protein electrophoresis.

The system uses precast Amersham ECL gels, which are available in a variety of concentrations and well configurations. Its horizontal format allows for easier sample application and reduced preparation time, the company said.

Protea Biosciences released this week new endoproteinases for protein digestion for use in protein identification and characterization by LC-MS/MS, de novo sequencing of unique proteins, and peptide mass fingerprinting by MALDI-MS.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.